Teva Pharmaceutical Industries (TEVA) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to -$1.5 billion.
- Teva Pharmaceutical Industries' Other Working Capital Changes fell 399189.19% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $83.0 million, marking a year-over-year decrease of 8870.75%. This contributed to the annual value of $81.0 million for FY2025, which is 8553.57% down from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Other Working Capital Changes stood at -$1.5 billion for Q4 2025, which was down 399189.19% from $561.0 million recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2021 and a low of -$4.2 billion during Q4 2021
- In the last 5 years, Teva Pharmaceutical Industries' Other Working Capital Changes had a median value of $82.5 million in 2021 and averaged -$137.3 million.
- In the last 5 years, Teva Pharmaceutical Industries' Other Working Capital Changes skyrocketed by 37924.53% in 2024 and then tumbled by 399189.19% in 2025.
- Teva Pharmaceutical Industries' Other Working Capital Changes (Quarter) stood at -$4.2 billion in 2021, then skyrocketed by 91.62% to -$348.0 million in 2022, then rose by 12.93% to -$303.0 million in 2023, then surged by 87.79% to -$37.0 million in 2024, then plummeted by 3991.89% to -$1.5 billion in 2025.
- Its Other Working Capital Changes was -$1.5 billion in Q4 2025, compared to $561.0 million in Q3 2025 and $336.0 million in Q2 2025.